JP2008511574A5 - - Google Patents

Download PDF

Info

Publication number
JP2008511574A5
JP2008511574A5 JP2007528777A JP2007528777A JP2008511574A5 JP 2008511574 A5 JP2008511574 A5 JP 2008511574A5 JP 2007528777 A JP2007528777 A JP 2007528777A JP 2007528777 A JP2007528777 A JP 2007528777A JP 2008511574 A5 JP2008511574 A5 JP 2008511574A5
Authority
JP
Japan
Prior art keywords
alkyl
alkoxy
disorder
methyl
disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007528777A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008511574A (ja
Filing date
Publication date
Priority claimed from GB0419315A external-priority patent/GB0419315D0/en
Priority claimed from GB0507386A external-priority patent/GB0507386D0/en
Priority claimed from GB0515010A external-priority patent/GB0515010D0/en
Application filed filed Critical
Priority claimed from PCT/EP2005/009379 external-priority patent/WO2006024517A1/en
Publication of JP2008511574A publication Critical patent/JP2008511574A/ja
Publication of JP2008511574A5 publication Critical patent/JP2008511574A5/ja
Pending legal-status Critical Current

Links

JP2007528777A 2004-08-31 2005-08-29 精神障害の治療のための縮合三環系誘導体 Pending JP2008511574A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB0419315A GB0419315D0 (en) 2004-08-31 2004-08-31 Compounds
GB0507386A GB0507386D0 (en) 2005-04-12 2005-04-12 Compounds
GB0515010A GB0515010D0 (en) 2005-07-21 2005-07-21 Compounds
PCT/EP2005/009379 WO2006024517A1 (en) 2004-08-31 2005-08-29 Fused tricyclic derivatives for the treatment of psychotic disorders

Publications (2)

Publication Number Publication Date
JP2008511574A JP2008511574A (ja) 2008-04-17
JP2008511574A5 true JP2008511574A5 (2) 2008-06-26

Family

ID=35106764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007528777A Pending JP2008511574A (ja) 2004-08-31 2005-08-29 精神障害の治療のための縮合三環系誘導体

Country Status (17)

Country Link
US (1) US20120022056A1 (2)
EP (1) EP1786822A1 (2)
JP (1) JP2008511574A (2)
KR (1) KR20070057885A (2)
CN (1) CN101048414B (2)
AR (1) AR053307A1 (2)
AU (1) AU2005279278A1 (2)
BR (1) BRPI0514377A (2)
CA (1) CA2578781A1 (2)
IL (1) IL181387A (2)
MA (1) MA28871B1 (2)
MX (1) MX2007002548A (2)
NO (1) NO20071326L (2)
NZ (1) NZ553506A (2)
PE (1) PE20060653A1 (2)
TW (1) TW200619221A (2)
WO (1) WO2006024517A1 (2)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0316915D0 (en) 2003-07-18 2003-08-20 Glaxo Group Ltd Compounds
US7898642B2 (en) 2004-04-14 2011-03-01 Asml Netherlands B.V. Lithographic apparatus and device manufacturing method
US8097610B2 (en) * 2005-08-26 2012-01-17 Shionogi & Co., Ltd. Derivative having PPAR agonistic activity
EP1978966A4 (en) * 2006-01-23 2010-11-10 Amira Pharmaceuticals Inc TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
WO2008005908A2 (en) 2006-07-07 2008-01-10 Forest Laboratories Holdings Limited Pyridoimidazole derivatives
BRPI0716539A2 (pt) 2006-09-07 2016-11-01 Emisphere Tech Inc métodos para sintetização de ácido n-(8-[2-hidroxibenzoil]amino) caprílico e de sal de sódio deste
JP2010504367A (ja) 2006-09-26 2010-02-12 グラクソ グループ リミテッド 性機能障害、認知障害、精神病性障害、不安、鬱病などを処置するための5ht1a受容体モジュレーターとしての5−{2−[4−(2−メチル−5−キノリニル)−l−ピペリジニル]エチル}キノリノン誘導体
JP2010520293A (ja) * 2007-03-07 2010-06-10 アラントス・フアーマシユーテイカルズ・ホールデイング・インコーポレイテツド 複素環式部分を含有するメタロプロテアーゼ阻害剤
EP2070933A1 (en) * 2007-12-07 2009-06-17 Laboratorios del Dr. Esteve S.A. Tricyclic triazolic compounds
GB0800840D0 (en) 2008-01-17 2008-02-27 Glaxo Group Ltd Novel salt
BRPI0909105A2 (pt) 2008-03-05 2015-08-25 Boehringer Ingelheim Int Derivados de piridina tricíclicos, composição farmacêutica e uso dos mesmos, bem como processos para preparar os ditos compostos e a dita composição farmacêutica
WO2010111626A2 (en) * 2009-03-27 2010-09-30 Takeda Pharmaceutical Company Limited Poly (adp-ribose) polymerase (parp) inhibitors
UY33229A (es) 2010-02-19 2011-09-30 Boehringer Ingelheim Int Derivados de piridina tricíclicos, medicamentos que contienen tales compuestos, su uso y proceso pa ra su preparación
WO2011153359A1 (en) 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
WO2012154731A1 (en) * 2011-05-08 2012-11-15 Vanderbilt University Substituted 1h-pyrrolo[3,2-c]quinolin-4(5h)-one analogs as positive allosteric modulators of the muscarinic acetylcholine receptor m4
EP2760868B1 (en) 2011-08-17 2018-04-25 Boehringer Ingelheim International GmbH Furo[3,4-c]quinoline derivatives, medicaments containing such compounds, their use and process for their preparation
EP2792679A1 (en) * 2013-04-19 2014-10-22 Laboratorios Del. Dr. Esteve, S.A. Tricyclic triazolic compounds
WO2014209978A1 (en) * 2013-06-24 2014-12-31 Merck Patent Gmbh Imidazole compounds as modulators of fshr and uses thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9706196A (es) * 1996-08-14 1998-02-28 Pfizer Compuestos triciclicos de piperidinilamino como antagonistas de la sustancia p.
IL124914A (en) * 1997-06-26 2000-10-31 Akzo Nobel Nv Pharmaceutical compositions containing 6-aryl-2,3,5,6-tetrahydroimidazo¬2,1-a¾isoquinoline derivatives and some new such compounds
US6919334B2 (en) * 2002-09-12 2005-07-19 Wyeth Antidepressant azaheterocyclymethyl derivatives of 4,5-dihydroimidazo[1,4,5-de][1,4]benzoxazine
GB0227240D0 (en) * 2002-11-21 2002-12-31 Glaxo Group Ltd Compounds

Similar Documents

Publication Publication Date Title
JP2008511574A5 (2)
TWI579284B (zh) 咪唑并吡咯啶酮化合物
JP2022505835A5 (2)
ES2299888T3 (es) Pirid (2,3-d)pirimidin-2,4-diaminas como inhibidores de pde 2.
AU2014219283C1 (en) Benzothiophene derivatives and compositions thereof as selective estrogen receptor degraders
JP2017533968A5 (2)
JP2014513110A5 (2)
JP5615902B2 (ja) イミダゾ[2,1−b][1,3,4]チアジアゾール誘導体
TW444013B (en) Quinoline and quinazoline compounds useful in treating benign prostatic hyperplasia
PE20141557A1 (es) Derivado de pirazoloquinolina
JP2016525076A5 (2)
JP2016522232A5 (2)
CA2474219A1 (en) Dihydrobenzodiazepin-2-one derivatives iii
JP2019512535A5 (2)
JP2015504067A5 (2)
JP2017524005A5 (2)
JP2020502103A5 (2)
RU2350616C2 (ru) Производные пиразоло- и имидазопиримидина
JP2005504080A5 (2)
JP2013544893A5 (2)
JP2013502431A5 (2)
JP2016525075A5 (2)
JP2005503345A5 (2)
RU2012141706A (ru) Производные оксадиазола и их применение в качестве потенцирующих средств в отношении метаботропных глутаматных рецепторов-842
JP2007512299A5 (2)